TJPC Trademark

Trademark Overview


On Wednesday, November 4, 2009, a trademark application was filed for TJPC with the United States Patent and Trademark Office. The USPTO has given the TJPC trademark a serial number of 79076099. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Saturday, August 29, 2020. This trademark is owned by Tianjin Pharmaceuticals Group Co., Ltd.. The TJPC trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes, namely, medicine for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, inflammatory disorder, gastroenterological disorders, and for use in dermatology, oncology, ophthalmology, hematology and in tissue and organ transplantation; raw material medicines, namely, chemical reagents for medical or veterinary purposes; active and intermediate pharmaceutical ingredients, namely, Amino acids for medical or veterinary purposes, Amino acids for nutritional purposes, Hormones and ...
tjpc

General Information


Serial Number79076099
Word MarkTJPC
Filing DateWednesday, November 4, 2009
Status706 - SECTION 71 ACCEPTED
Status DateSaturday, August 29, 2020
Registration Number3896572
Registration DateTuesday, December 28, 2010
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 12, 2010

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the letters "TJPC" and a design of two birds within a circle.
Goods and ServicesMedicines for human purposes, namely, medicine for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, inflammatory disorder, gastroenterological disorders, and for use in dermatology, oncology, ophthalmology, hematology and in tissue and organ transplantation; raw material medicines, namely, chemical reagents for medical or veterinary purposes; active and intermediate pharmaceutical ingredients, namely, Amino acids for medical or veterinary purposes, Amino acids for nutritional purposes, Hormones and Steroids; dietetic foods adapted for medical purposes
Pseudo MarkTIANJIN PHARMACEUTICALS CO

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 24, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTianjin Pharmaceuticals Group Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTianjin
CN

Party NameTianjin Pharmaceuticals Group Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCN

Party NameTianjin Pharmaceuticals Group Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCN

Trademark Events


Event DateEvent Description
Saturday, August 29, 2020NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Saturday, August 29, 2020REGISTERED-SEC.71 ACCEPTED
Wednesday, August 26, 2020TEAS SECTION 71 RECEIVED
Saturday, December 28, 2019COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Thursday, November 21, 2019INTERNATIONAL REGISTRATION RENEWED
Tuesday, April 25, 2017NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Tuesday, April 25, 2017REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Tuesday, April 25, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, November 18, 2016TEAS SECTION 71 & 15 RECEIVED
Monday, February 18, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, April 28, 2011FINAL DISPOSITION NOTICE SENT TO IB
Thursday, April 28, 2011FINAL DISPOSITION PROCESSED
Monday, March 28, 2011FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 28, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, October 12, 2010PUBLISHED FOR OPPOSITION
Wednesday, September 22, 2010NOTICE OF PUBLICATION
Friday, September 3, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 3, 2010ASSIGNED TO LIE
Saturday, August 21, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 16, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, August 14, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, August 14, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 12, 2010REFUSAL PROCESSED BY IB
Wednesday, February 17, 2010NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, February 17, 2010REFUSAL PROCESSED BY MPU
Wednesday, February 17, 2010NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, February 16, 2010NON-FINAL ACTION WRITTEN
Wednesday, February 10, 2010ASSIGNED TO EXAMINER
Tuesday, December 29, 2009APPLICATION FILING RECEIPT MAILED
Thursday, December 24, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 17, 2009SN ASSIGNED FOR SECT 66A APPL FROM IB